首页> 外国专利> Hidroxiquinolina derived compounds and Nitrogen Heterocycles, antagonists of Muscarinic Receptors and beta2 adrenergic receptor agonists, Pharmaceutical composition, Pharmaceutical Combination; and its use for the Treatment or prevention of Asthma, chronic bronchitis and COPD.

Hidroxiquinolina derived compounds and Nitrogen Heterocycles, antagonists of Muscarinic Receptors and beta2 adrenergic receptor agonists, Pharmaceutical composition, Pharmaceutical Combination; and its use for the Treatment or prevention of Asthma, chronic bronchitis and COPD.

机译：Hidroxiquinolina衍生的化合物和氮杂环化合物，毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂，药物组合物，药物组合;及其用于治疗或预防哮喘，慢性支气管炎和COPD的用途。

页面导航

摘要
著录项
相似文献

摘要

FIELD OF THE INVENTION The present invention relates to compounds acting both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists, to processes for their preparation, to compositions comprising them, to therapeutic uses and combinations with other pharmaceutical active ingredients.

机译：发明领域本发明涉及同时用作毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂的化合物，其制备方法，包含它们的组合物，治疗用途以及与其他药物活性成分的组合。

著录项

公开/公告号CL2015001483A1

专利类型
公开/公告日2015-10-23

原文格式PDF
申请/专利权人 CHIESI FARMACEUTICI S.P.A.;
展开▼

申请/专利号CL20150001483
发明设计人 RANCATI FABIO;LINNEY IAN;
展开▼

申请日2015-06-02
分类号C07D453/02;A61K31/4709;A61P11/06;A61P11/08;
国家 CL
入库时间 2022-08-21 15:15:50

相似文献

专利
外文文献
中文文献